Primary Site >> Stomach Cancer
Gene >> CD46
| 1. | |||||||||||
| Journal: | J Surg Oncol. 1997 Mar;64(3):222-30. | ||||||||||
| Title: | Frequent expression of complement resistance factors CD46, CD55, and CD59 on gastrointestinal cancer cells limits the therapeutic potential of monoclonal antibody 17-1A. | ||||||||||
| Author: | Juhl, H|Helmig, F|Baltzer, K|Kalthoff, H|Henne-Bruns, D|Kremer, B | ||||||||||
| PMID: | 9121154 | ||||||||||
| 2. | |||||||||||
| Journal: | Mol Pathol. 2002 Jun;55(3):193-9. | ||||||||||
| Title: | Expression of complement regulating factors in gastric cancer cells. | ||||||||||
| Author: | Inoue, T|Yamakawa, M|Takahashi, T | ||||||||||
| PMID: | 12032231 | ||||||||||
| 3. | |||||||||||
| Journal: | Mol Oncol. 2013 Jun;7(3):580-94. | ||||||||||
| Title: | Lipoplex mediated silencing of membrane regulators (CD46, CD55 and CD59) enhances complement-dependent anti-tumor activity of trastuzumab and pertuzumab. | ||||||||||
| Author: | Mamidi, Srinivas|Cinci, Marc|Hasmann, Max|Fehring, Volker|Kirschfink, Michael | ||||||||||
| PMID: | 23474221 | ||||||||||